Helen Phillips
Corporate Officer/Principal at AMRYT PHARMA PLC
Network origin in Helen Phillips first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 15 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Helen Phillips via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Founder Director/Board Member Director/Board Member Compliance Officer Director/Board Member Director/Board Member Director/Board Member Director/Board Member General Counsel Public Communications Contact Human Resources Officer Chief Tech/Sci/R&D Officer | |
| GAMIDA CELL LTD. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer Chief Executive Officer Corporate Officer/Principal | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President Director/Board Member Director/Board Member | |
| CHIASMA, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
American Bar Association
 American Bar Association Miscellaneous Commercial ServicesCommercial Services American Bar Association provides legal services. It provides law school accreditation, continuing legal education, legal information and other services to assist legal professionals. The firm has members which include judges, court administrators, law professors, and non-practicing attorneys. The company was founded on August 21, 1878 and is headquartered in Chicago, IL. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal | |
| Eyam Vaccines & Immunotherapeutics Ltd. | Director/Board Member | ||
| The Pennsylvania State University | College/University | Undergraduate Degree | |
| Rutgers Law School | College/University | Graduate Degree | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Compliance Officer | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Compliance Officer | |
| AMPIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| South Asian Bar Association of North America | Director/Board Member | ||
| BLUE FOUNDRY BANCORP | Savings Banks | Director/Board Member | |
| City of Philadelphia (Pennsylvania) | Municipality | Corporate Officer/Principal | |
Women's Way
 Women's Way Investment Trusts/Mutual FundsMiscellaneous Women''s Way is a non-profit organization, which committed to gender equality and justice. The company is headquartered in Philadelphia, PA. | Investment Trusts/Mutual Funds | Director/Board Member | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Compliance Officer | |
Blue Foundry Bank
 Blue Foundry Bank Savings BanksFinance Part of Blue Foundry Bancorp, Blue Foundry Bank is a state chartered savings bank. The company is based in Rutherford, NJ. James Domenick Nesci has been the CEO of the company since 2018. | Savings Banks | Director/Board Member | |
| The Hebrew University of Jerusalem | College/University | Doctorate Degree | |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Chiasma (Israel) Ltd. | Director/Board Member | ||
| ADVAXIS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| AUXILIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Compliance Officer | |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Biotechnology | Compliance Officer | |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Compliance Officer | |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Micreos BV
 Micreos BV Pharmaceuticals: GenericHealth Technology Micreos BV develops phage-based products against specific dangerous bacteria. It offers human health, food safety, agriculture and animal health products. The company was founded by Mark Offerhaus and is headquartered in Wageningen, the Netherlands. | Pharmaceuticals: Generic | Chairman | |
| ADVANZ PHARMA CORP. LIMITED | Pharmaceuticals: Major | Director/Board Member | |
NMD Pharma A/S
 NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark. | Biotechnology | Chairman | |
| ARCH BIOPARTNERS INC. | Pharmaceuticals: Major | Director/Board Member | |
PIQUR Therapeutics AG
 PIQUR Therapeutics AG Pharmaceuticals: OtherHealth Technology PIQUR Therapeutics AG engages in development of anti-cancer drugs based on the inhibition. Its products include PQR309, PQR620 and PQR5xx. The company was founded by Bernd Giese, Vladimir Cmiljanovic, Andreas Emmenegger, Ralf Rosenow and Matthias Wymann in August 2011 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Other | Chairman | |
| SANTHERA PHARMACEUTICALS HOLDING AG | Pharmaceuticals: Major | Director/Board Member | |
| CIRCIO HOLDING ASA | Biotechnology | Chairman | |
Targovax Oy
 Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | Pharmaceuticals: Major | Chairman | |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Consultant / Advisor | |
BiognoSYS AG
 BiognoSYS AG Packaged SoftwareTechnology Services BiognoSYS AG operates as a biotechnology company. Its products include iRT Kit, HRM Kit, Sample Prep Kit, PlasmaDive, Spectronaut and SpectroDive. The company was founded by Philipp M. Antoni, Johan Malmstroem and Oliver Rinner on September 3, 2008 and is headquartered in Schlieren, Switzerland. | Packaged Software | Chairman | |
| Gyrus Capital SA | Investment Managers | Private Equity Investor | |
Essential Pharmaceuticals Ltd.
 Essential Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Essential Pharmaceuticals Ltd. manufactures pharmaceutical products. The company was founded on November 24, 2010 and is headquartered in Egham, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
| SQZ BIOTECHNOLOGIES COMPANY | Biotechnology | Director/Board Member | |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor | |
| F2g Inc. | Director/Board Member | ||
Essential Pharmaceuticals LLC
 Essential Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Intas Pharmaceuticals Ltd., Essential Pharmaceuticals LLC is a company that manufactures and markets pharmaceutical products. The company is based in Durham, NC. The company was founded in 2006. Emma Jane Johnson has been the CEO of the company since 2023. Essential Pharmaceuticals was acquired by Accord Healthcare, Inc. on July 26, 2017. | Pharmaceuticals: Major | Chairman | |
Athyrium Capital Management LP
 Athyrium Capital Management LP Investment ManagersFinance Athyrium Capital Management LP (Athyrium) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey A. Ferrell in 2008 as Athyrium Capital Management LLC and converted from a Delaware limited liability company to a Delaware limited partnership in 2015. Athyrium provides advisory services on a discretionary basis to its clients, which may include specific tailored vehicles and pooled investment vehicles intended for sophisticated investors and institutional investors. | Investment Managers | Consultant / Advisor | |
| Harvard Medical School | College/University | Graduate Degree | |
| PALATIN TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Blue Cross & Blue Shield of Massachusetts, Inc.
 Blue Cross & Blue Shield of Massachusetts, Inc. Miscellaneous Commercial ServicesCommercial Services Blue Cross & Blue Shield of Massachusetts, Inc. provides indemnity insurance and medicare extension programs. The firm offers medical and dental plans, pharmacy coverage, vision coverage and health savings accounts. The company was founded in 1937 and is located in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| POOLBEG PHARMA PLC | Pharmaceuticals: Major | General Counsel | |
| AERIE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| I-MAB | Pharmaceuticals: Major | Chief Executive Officer | |
I-MAB Biopharma Co., Ltd.
 I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Biotechnology | Chief Executive Officer |
Statistics
International
| United States | 29 |
| United Kingdom | 7 |
| Israel | 5 |
| Switzerland | 5 |
| Canada | 3 |
Sectoral
| Health Technology | 32 |
| Finance | 7 |
| Consumer Services | 5 |
| Commercial Services | 3 |
| Government | 2 |
Operational
| Director/Board Member | 84 |
| Corporate Officer/Principal | 39 |
| Chairman | 26 |
| Independent Dir/Board Member | 26 |
| Chief Executive Officer | 19 |
Most connected contacts
| Insiders | |
|---|---|
| Alain Munoz | 38 |
| Patrick Volkert Vink | 30 |
| Stephen Wills | 22 |
| Elizabeth Jobes | 18 |
| Donald Stern | 15 |
| Joe Wiley | 14 |
| Rory Nealon | 11 |
| Rajkumar Kannan | 11 |
| Roni Mamluk | 9 |
| George Hampton | 8 |
| John McEvoy | 8 |
| Stephen Joyce | 6 |
| Ray Stafford | 5 |
| Julie Eastwood | 5 |
| Tracy Cunningham | 5 |
- Stock Market
- Insiders
- Helen Phillips
- Company connections
